Shaping the Future of Heart Health- An Analysis of the Indian Cardiology Market

Published: Jul 2024

Indian cardiology market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2024-2031). The key factors influencing the market growth of Indian cardiology are increasing incidence of cardiovascular diseases, frequent technology updates in cardiovascular devices, reforms in the pricing and government policies which led to the availability of devices, entry of Indian manufacturers in the global markets, and enhanced investment in R&D and collaboration in manufacturing. 

Browse the full report description of “Indian Cardiology Market Size, Share & Trends Analysis Report by Cardiology Device Types (Cardiovascular Stents, Cardiovascular Catheters, Cardiac Rhythm Management Devices, and Cardiovascular Assistive Devices), by Drugs Types (Antithrombotic Drugs, Antidyslipidemic Drugs, Antihypertensive Drugs, and Anti-Stroke Drugs) by Surgery Types (Coronary Artery Bypass Grafting, Transmyocardial Laser Revascularization, Heart Valve Repair, Cardiac Resynchronization Therapy (CRT), Aneurysm Repair, and Heart Transplant) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/indian-cardiology-market-size

Recent Developments

  • In April 2023, the Indian Institute of Technology Madras introduced ARTSENS, a noninvasive diagnostic tool for blood vessel evaluation. It can detect cardiovascular diseases at an early stage, and the device is easy to use, enabling simple check-ups from laymen. 
  • In September 2022, GE Healthcare introduced the Optima IGS 320 Cath Lab, an AI-powered product, to the Indian market. This is an interventional imaging software that enhances cardiac care by providing detailed, non-invasive treatments and automating the AutoRight function to lighten the load of an interventionalist while helping deliver more purposeful care.

Market Coverage

The market number available for – 2023-2031

Base year- 2023

Forecast period- 2024-2031

Segment Covered- 

o By Cardiology Device Type

o By Drugs Type

o By Surgery Type

Competitive Landscape- Boston Scientific Corp., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., and Medtronic PLC among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Indian Cardiology Market Report Segment

By Cardiology Device Type

  • Cardiovascular Stents
  • Cardiovascular Catheters
  • Cardiac Rhythm Management Devices
  • Cardiovascular Assistive Devices

By Drugs Type 

  • Antithrombotic Drugs
  • Antidyslipidemic Drugs
  • Antihypertensive Drugs
  • Anti-Stroke Drugs

 By Surgery Types

  • Coronary Artery Bypass Grafting
  • Transmyocardial Laser Revascularization
  • Heart Valve Repair
  • Cardiac Resynchronization Therapy (CRT)
  • Aneurysm Repair
  • Heart Transplant


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-cardiology-market-size